Effect of phyllanthus niruri on metabolic parameters of patients with kidney stone: a perspective for disease prevention
Carregando...
Citações na Scopus
34
Tipo de produção
article
Data de publicação
2018
Título da Revista
ISSN da Revista
Título do Volume
Editora
BRAZILIAN SOC UROL
Citação
INTERNATIONAL BRAZ J UROL, v.44, n.4, p.758-764, 2018
Resumo
Phyllanthus niruri (P.niruri) or stone breaker is a plant commonly used to reduce stone risk, however, clinical studies on this issue are lacking. Objective: To prospectively evaluate the effect of P. niruri on the urinary metabolic parameters of patients with urinary lithiasis. Materials and Methods: We studied 56 patients with kidney stones < 10mm. Clinical, metabolic, and ultrasonography assessment was conducted before (baseline) the use of P. niruri infusion for 12-weeks (P. niruri) and after a 12-week (wash out) Statistical analysis included ANOVA for repeated measures and Tukey's/McNemar's test for categorical variables. Significance was set at 5%. Results: Mean age was 44 +/- 9.2 and BMI was 27.2 +/- 4.4kg/m2. Thirty-six patients (64%) were women. There were no significant changes in all periods for anthropometric and several serum measurements, including total blood count, creatinine, uric acid, sodium, potassium, calcium, urine volume and pH; a significant increase in urinary potassium from 50.5 +/- 20.4 to 56.2 +/- 21.8 mg/24-hour (p=0.017); magnesium/creatinine ratio 58 +/- 22.5 to 69.1 +/- 28.6mg/gCr24-hour (p=0.013) and potassium/creatinine ratio 39.3 +/- 15.1 to 51.3 +/- 34.7mg/gCr24hour (p=0.008) from baseline to wash out. The kidney stones decreased from 3.2 +/- 2 to 2.0 +/- 2per patient (p<0.001). In hyperoxaluria patients, urinary oxalate reduced from 59.0 +/- 11.7 to 28.8 +/- 16.0mg/24-hour (p=0.0002), and in hyperuricosuria there was a decrease in urinary uric acid from 0.77 +/- 0.22 to 0.54 +/- 0.07mg/24-hour (p=0.0057). Conclusions: P. niruri intake is safe and does not cause significant adverse effects on serum metabolic parameters. It increases urinary excretion of magnesium and potassium caused a significant decrease in urinary oxalate and uric acid in patients with hyperoxaluria and hyperuricosuria. The consumption of P. niruri contributed to the elimination of urinary calculi.
Palavras-chave
Kidney Calculi, Disease, Urolithiasis
Referências
- Bagalkotkar G, 2006, J PHARM PHARMACOL, V58, P1559, DOI 10.1211/jpp.58.12.0001
- Barros ME, 2006, UROL RES, V34, P351, DOI 10.1007/s00240-006-0065-1
- Bikle DD, 1997, AM J MED, V103, P427, DOI 10.1016/S0002-9343(97)00137-X
- Campos AH, 1999, NEPHRON, V81, P393, DOI 10.1159/000045322
- Cardiology Society of Brazilian Hypertension Society of Brazilian Company Brazilian Nephrology, 2010, ARQ BRAS CARDIOL, V95, P1
- Cruces I.L, 2013, Rev. bras. plantas med., V15, P780, DOI 10.1590/S1516-05722013000500020
- Curhan GC, 2004, ARCH INTERN MED, V164, P885, DOI 10.1001/archinte.164.8.885
- Devi M.V., 1986, J RES ED IND MED, V5, P11
- Ettinger B, 1997, J UROLOGY, V158, P2069, DOI 10.1016/S0022-5347(01)68155-2
- Fahmy NM, 2012, UROLOGY, V79, P43, DOI 10.1016/j.urology.2011.07.1387
- Freitas AM, 2002, BJU INT, V89, P829, DOI 10.1046/j.1464-410X.2002.02794.x
- Micali S, 2006, J UROLOGY, V176, P1020, DOI 10.1016/j.juro.2006.04.010
- Murugaiyah V, 2009, J ETHNOPHARMACOL, V124, P233, DOI 10.1016/j.jep.2009.04.026
- Nishiura J, 2004, UROL RES, V32, P362, DOI 10.1007/s00240-004-0432-8
- Pearle MS, 2005, J UROLOGY, V173, P848, DOI 10.1097/01.ju.0000152082.14384.d7
- Ramsout R, 2011, EUROPEAN UROLOGY S, V10, P461
- Reungjui S, 2002, BJU INT, V90, P635, DOI 10.1046/j.1464-4096.2002.03015.x
- Stamatelou KK, 2003, KIDNEY INT, V63, P1817, DOI 10.1046/j.1523-1755.2003.00917.x
- Udupa A. L., 2010, Health, V2, P511, DOI 10.4236/health.2010.25076
- Wang BE, 2000, J GASTROEN HEPATOL, V15, pE67, DOI 10.1046/j.1440-1746.2000.02100.x
- Worcester EM, 2008, SEMIN NEPHROL, V28, P120, DOI 10.1016/j.semnephrol.2008.01.005